A Diabetes Mobile App With In-App Coaching From a Certified Diabetes Educator Reduces A1C for Individuals With Type 2 Diabetes

被引:43
|
作者
Kumar, Shefali [1 ]
Moseson, Heidi [1 ]
Uppal, Jaspreet [1 ]
Juusola, Jessie L. [1 ]
机构
[1] Evidat Hlth, 167 2nd Ave, San Mateo, CA 94401 USA
来源
DIABETES EDUCATOR | 2018年 / 44卷 / 03期
关键词
SELF-MANAGEMENT EDUCATION; POSITION STATEMENT; GLYCEMIC CONTROL; DISTRESS; DEPRESSION; MELLITUS; ADULTS; CARE;
D O I
10.1177/0145721718765650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose There are currently many diabetes apps available, but there is limited evidence demonstrating clinical impact. The purpose of this study is to evaluate the impact of a diabetes mobile app with in-app coaching by a certified diabetes educator on glycemic control for individuals with type 2 diabetes. Methods A 12 week-long single-arm intent-to-treat trial evaluated the impact of a diabetes mobile app and coaching program (One Drop | Mobile With One Drop | Experts), which facilitated tracking of self-care and included an in-app diabetes education program, on A1C for individuals with type 2 diabetes and an A1C 7.5% (58 mmol/mol). An online study platform (Achievement Studies, Evidation Health Inc, San Mateo, CA) was used to screen, consent, and enroll participants; collect study data; and track participants' progress throughout the study. Baseline and study end A1C measurements as well as questionnaire data from participants were collected. Results Participants (n = 146) were 52 9 years old, 71% female, 25% black or Hispanic, diagnosed with diabetes for 11 +/- 7 years, and with a mean baseline A1C of 9.87% +/- 2.0 (84 mmol/mol). In adjusted repeated measures models, mean A1C improved by -0.86% among study completers (n = 127), -0.96% among active users of the app and coaching program (n = 93), and -1.32% among active users with a baseline A1C 9.0% (75 mmol/mol) (n = 53). Conclusions This program was associated with a clinically meaningful and significant reduction in A1C and can potentially increase access to effective diabetes self-management education and support for individuals with diabetes.
引用
收藏
页码:225 / 236
页数:12
相关论文
共 50 条
  • [41] Type 2 Diabetes Mellitus: Managing Hemoglobin A1c and Beyond
    Fowler, Grant C.
    Vasudevan, Deepa A.
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (09) : 911 - 916
  • [42] DIFFERENCES IN PSYCHOSOCIAL FUNCTIONING IN INDIVIDUALS WITH TYPE 1 DIABETES UTILIZING CLINICAL CUTOFFS FOR A1C
    Neiman, Jamie S.
    Bento, Samantha P.
    Monaghan, Maureen
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S297 - S297
  • [43] Hemoglobin A1c predictive for Type 2 diabetes in older women
    不详
    BIOMARKERS IN MEDICINE, 2007, 1 (03) : 344 - 344
  • [44] Limitations of hemoglobin A1C in the management of type 2 diabetes mellitus
    Zhu, Nemin Adam
    Reichert, Sonja
    Harris, Stewart B.
    CANADIAN FAMILY PHYSICIAN, 2020, 66 (02) : 112 - 114
  • [45] Adolescent Mobile Phone Use for Diabetes Varies With A1C
    Kumah-Crystal, Yaa
    Rothman, Russell
    Mulvaney, Shelagh
    DIABETES, 2013, 62 : A682 - A682
  • [46] rEffects of Pramlintide on A1C, Weight, and Hypoglycemia in Patients With Type 1 or Type 2 Diabetes: Subgroup Analysis by Duration of Diabetes
    Herrmann, Kathrin
    Brunell, Steven C.
    Shan, Kevin
    Chen, Steve
    DIABETES, 2013, 62 : A267 - A267
  • [48] GoCARB. Smartphone app for carbohydrate calculation in type 1 diabetes
    Laimer, M.
    Stettler, C.
    Diem, P.
    Mougiakakou, S.
    DIABETOLOGE, 2015, 11 (07): : 575 - 578
  • [49] Serum glycated albumin to haemoglobin A1C ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus
    Koga, Masafumi
    Murai, Jun
    Saito, Hiroshi
    Kasayama, Soji
    Imagawa, Akihisa
    Hanafusa, Toshiaki
    Kobayashi, Tetsuro
    ANNALS OF CLINICAL BIOCHEMISTRY, 2010, 47 : 313 - 317
  • [50] A MOBILE-APP ASSISTED CARBOHYDRATE COUNTING STRATEGY IMPROVES GLUCOSE CONTROL IN TYPE 1 DIABETES
    Briganti, S. I.
    Strollo, R.
    Maggi, D.
    Kyanvash, S.
    Pozzilli, P.
    Manfrini, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A154 - A154